|Received:||6/28/2006 10:16:11 PM|
|Subject:||Business Opportunity Rule|
|Title:||Notice of Proposed Rulemaking|
|CFR Citation:||16 CFR Part 437|
Comments:The rules the FTC is proposing that would affect Quixtar IBOs are onerous in the extreme and entirely unneccessary. They will do NOTHING to prevent the bad businesses continuing what they are doing. The ones I personally object to most strenuously are: 1) the requirements to list other IBOs and their contact information. What is to stop them from trying to sponsor the contact themselves? And would I want my personal contact information given out to many people I don’t know and have no control over? 2) the financial disclosure. Is there ANY other profession where the practitioner would have to disclose highly personal information like this in order to get the client’s business? Would you go and ask your doctor what her income is before you let her treat you? To demand of us that we reveal this kind of information is highly inappropriate. 3) the requirement for disclosure of legal actions. Would this include all the frivolous claims that have no basis in truth? 4) the 7-day waiting period. What is the reason for this? We offer a full money-back guarantee; this should suffice.